Rhythm Pharmaceuticals (RYTM) Other Working Capital Changes (2016 - 2026)
Rhythm Pharmaceuticals' (RYTM) quarterly Other Working Capital Changes came in at $487000.0 in Q1 2026, up 137.87% year-on-year from $204734.2 in Q1 2025, and up 151.03% on a QoQ basis from $194000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 11 years of Other Working Capital Changes data on file, last reported at $487000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 137.87% year-over-year to $487000.0 in Q1 2026; TTM through Mar 2026 was $681000.0, a 118.37% increase from a year earlier, with the FY2025 full-year figure at -$1.1 million, changed N/A from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $487000.0, up from $194000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for RYTM reached as high as $3.2 million in Q3 2022 and fell as low as -$2.7 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged -$284214.3 across 5 years, with a median of -$74000.0 in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 40450.0% in 2024 and fell as far as 1807.04% in 2024.
- Year by year, Other Working Capital Changes stood at -$972000.0 in 2022, then sank by 180.66% to -$2.7 million in 2023, then jumped by 106.63% to $181000.0 in 2024, then rose by 7.18% to $194000.0 in 2025, then jumped by 151.03% to $487000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $487000.0 in Q1 2026, $194000.0 in Q4 2025, and -$1.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rhythm Pharmaceuticals | 6.98 Bn | 6.64 Bn | 52.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 487,000.00 |
| Mar 31, 2026 | 487,000.00 |
| Mar 31, 2026 | 487,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Mar 31, 2025 | -1.29 Mn |
| Mar 31, 2025 | -1.29 Mn |
| Mar 31, 2025 | -1.29 Mn |
| Dec 31, 2024 | 181,000.00 |
| Dec 31, 2024 | 181,000.00 |
| Dec 31, 2024 | 181,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Sep 30, 2024 | 106,000.00 |
| Jun 30, 2024 | -2.71 Mn |
| Jun 30, 2024 | -2.71 Mn |
| Jun 30, 2024 | -2.71 Mn |
| Mar 31, 2024 | 2.42 Mn |
| Mar 31, 2024 | 2.42 Mn |